We’re pleased to welcome Christopher Hill, PhD, Executive Director of Chemistry, and Ian Waddell, PhD, Executive Director of Biology, to our Discovery team.
Dr. Patricia Turner will utilize her 25 years of veterinary sciences experience to lead our global animal welfare, enrichment, and humane care initiatives.
Easily find exactly what you want on the all-new criver.com this December, featuring a fresh look, improved navigation and search, and comprehensive resource library.
Bioassays and protein characterization services take center stage in our new laboratories.
Robin, David, and Rodney are the newest members of the North American Research Models management team.
The Orbitrap Fusion™ allows for advanced characterization of synthetic peptides, complex protein samples, and glycoproteins along with accurate quantitation of host cell proteins.
New advances in combining linker and capture technologies with in-depth knowledge of how these are attached to phenotypic molecules of interest, combined with powerful LC-MS techniques such as the Capture Compound Mass Spectrometry (CCMS) technology, enables scientists to better identify target proteins that are responsible for the phenotypic response.
Ferrets (Mustela putorius) and cotton rats (Sigmodon hispidus) are the primary animals used in vaccine development for infectious respiratory diseases such as influenza, RSV and hMPV. The availability of these and other suitable animal models is an essential component in the development and final lot release of many other human and veterinary infectious disease vaccines.
Dr. Devanarayan was recently hired as the new Executive Director for Global Safety Assessment Statistics and Data Sciences across our relevant functional units and sites.
Following redevelopment, our Lyon facility now boasts flexible housing for different species within a single building.